Sutro Biopharma, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficit) (Tables)

12 Months Ended

Dec. 31, 2019

As of December 31, 2019 and 2018, the Company had reserved common stock, on an if-converted basis, for issuance as follows:

	December 31,
	2019		2018
Common stock options issued and outstanding		3,872,664		3,111,718
Common stock awards issued and outstanding		335,799		311,240
Remaining shares reserved for issuance under 2004 and 2018 Equity Incentive Plan		2,750,416		2,525,610
Shares reserved for issuance under 2018 Employee Stock Purchase Plan		326,542		230,000
Warrants to purchase common stock		71,813		71,813
Total		7,357,234		6,250,381